(FM) Patología, Anatomía y Fisiología
Departamento académico
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (11)
2021
2019
-
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 343-357
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
2017
-
Dual modulation of MCL-1 and mTOR determines the response to sunitinib
Journal of Clinical Investigation, Vol. 127, Núm. 1, pp. 153-168
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2015
-
Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types
Journal of the National Cancer Institute, Vol. 107, Núm. 12
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633
2013
-
A prognostic DNA methylation signature for stage I non-small-cell lung cancer
Journal of Clinical Oncology, Vol. 31, Núm. 32, pp. 4140-4147
2012
-
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort
European Respiratory Journal, Vol. 40, Núm. 1, pp. 177-184
2009
-
EUELC project: A multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
European Respiratory Journal, Vol. 34, Núm. 6, pp. 1477-1486